Chi-Med files application to list in Hong Kong and announces proposed global offering
HONG KONG: Hutchison China MediTech Limited, the commercial-stage biopharmaceutical company focused on discovery, development and commercialization of targeted therapies and immunotherapies for oncology and immunological diseases, has submitted a listing…